COMMUNIQUÉS West-GlobeNewswire

TRHC Praises Signing of SUPPORT for Patients and Communities Act
01/11/2018
MOORESTOWN, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, applauds the signing into law of the [...]
Catalyst Biosciences Reports Third Quarter Operating & Financial Results and Provides a Corporate Update
01/11/2018
Presented Updated Positive Interim Data from the Phase 2/3 Study of Marzeptacog Alfa (Activated) (FVIIa) at Two Scientific Meetings Published Data from Phase 1 Study of Marzeptacog Alfa (Activated) in the Journal of [...]
MannKind Corporation Reports 2018 Third Quarter Financial Results
01/11/2018
Conference Call to Begin Today at 9:00 AM ET Executed license and collaboration agreement with United Therapeutics for up to $95 million in upfront and milestone payments plus royalties Executed research agreement for a [...]
Radius Health Announces Third Quarter 2018 Operating Results and Financial Guidance for FY 2018 and FY 2019
01/11/2018
TYMLOS® U.S. net sales continued to increase in the third quarter of 2018, totaling $27.6 million. 2019 Medicare Part D coverage for TYMLOS increased from 44% to 64% Elacestrant Phase 3 study to target a broader patient [...]
Announcement no. 10/2018 - Annual Report 2017/18 and Corporate Responsibility Report
01/11/2018
Please see enclosed pdf files. Attachments Annual Report 2017-18 CR Report 2017_18
Coloplast delivers solid full-year result and 8% growth for the sixth quarter running
01/11/2018
Coloplast delivered 8% organic revenue growth in the fourth quarter of the 2017/18 financial year and 8% full-year organic revenue growth as well as a 31% EBIT margin. The company is guiding for ~8% organic revenue [...]
Announcement no. 9/2018 - Full-year Financial Results 2017/18
01/11/2018
2017/18 Announcement of full-year financial results 2017/18 (01 October 2017 - 30 September 2018) Highlights Lars Rasmussen steps down as CEO of Coloplast A/S. The Board of Directors appoints Kristian Villumsen as new [...]
Lars Rasmussen resigns his position as CEO of Coloplast A/S. The board has appointed current Executive Vice President for Coloplast Chronic Care, Kristian Villumsen, as new CEO of the company.
01/11/2018
After 30 years in Coloplast, 17 of them in Executive Management and 10 years as CEO, Lars Rasmussen has decided to resign his position as CEO of Coloplast A/S as of December 4 th, 2018. Succeeding Lars, who during his [...]
Announcement no. 8/2018 - Lars Rasmussen steps down as CEO of Coloplast A/S
01/11/2018
Announcement No. 08/2018 1 November 2018 Lars Rasmussen steps down as CEO of Coloplast A/S. The Board of Directors appoints Kristian Villumsen as new CEO of Coloplast A/S. Coloplast A/S announces today that after 30 [...]
Nephros to Report Third Quarter 2018 Financial Results on November 8th, 2018
01/11/2018
SOUTH ORANGE, NJ, Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, [...]
Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business
01/11/2018
Sunnyvale, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that management and staff are commemorating its 25-year business anniversary. [...]
AC Immune to Host Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and the Involvement of Other Misfolded Proteins in AD and Neurodegenerative Diseases
01/11/2018
Key Opinion Leaders to discuss emerging concepts in the development of therapies for Alzheimer's Disease and other neurodegenerative diseases Meeting scheduled for November 5, 2018, from 12:00pm - 2:00pm ET AC Immune's [...]
Amarin Reports Third Quarter 2018 Financial Results and Provides Update on Operations
01/11/2018
Activities Underway to Support Planned Commercial Expansion Management to Host Conference Call at 7:30 a.m. ET Today BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc ( [...]
OV - Clinical up-date
01/11/2018
Clinical up-date : Oncology Venture aims for approval of LiPlaCis ® based on pivotal study in less than 200 patients Hoersholm, Denmark and Cambridge, MA, US, November 1, 2018 - Oncology Venture A/S ("OV" or "the [...]
Notice to convene the Annual General Meeting 2018
01/11/2018
Company Announcement No. 19 / 2018 November 1, 2018 The Annual General Meeting of Chr. Hansen Holding A/S will be hold on Thursday November 29, 2018 at 4:00 p.m. CET at the Company’s premises, Bøge Allé 10-12, 270 [...]
Orion Research Foundation grants million euros for research in 2019
01/11/2018
Orion Research Foundation sr Press release 1 November 2018 at 9.30 a.m. Orion Research Foundation grants million euros for research in 2019 Orion Research Foundation sr is distributing EUR 1,004,800 in research grants [...]
Henrik Juuel Joins Bavarian Nordic as Chief Financial Officer
01/11/2018
COPENHAGEN, Denmark, November 1, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that Henrik Juuel today has taken up the position as Executive Vice President and Chief Financial Officer (CFO) of Bavarian [...]
Rule 2.9 Announcement
01/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 November 2018 [...]
Form 8 (DD) - Flemming Ornskov
01/11/2018
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the “Code”) [...]

Pages